Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Hung-Chin Tsai, MD

Kaohsiung Veterans General Hospital, Taiwan

Disclosure(s): No financial relationships to disclose

Poster(s):

(P-792) Evaluation of the efficacy and safety of a short-course, daily, 4-month regimen including isoniazid, pyrazinamide, rifapentine and moxifloxacin (2HZPM/2HPM) for the treatment of drug-susceptible pulmonary tuberculosis in Taiwan (ESCAPE-TB): A multicenter study

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT